Haisco Pharmaceutical Group Company Description

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China.

The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases.

The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016.

Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Haisco Pharmaceutical Group Co., Ltd.

Country	China
Founded	2000
Industry	Biotechnology
Sector	Healthcare
Employees	5,337
CEO	Xiu Lian Fan

Contact Details

Address: No. 17 Sanxiang Avenue Shannan, 856000 China
Phone	86 89 3783 4865
Website	haisco.com

Stock Details

Ticker Symbol	002653
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100001BC7
SIC Code	2834

Key Executives

Name	Position
Xiu Lian Fan	MD, GM and Director
Peng Duan	Chief Financial Officer
Meng Wang	Deputy GM and Board Secretary
Han Bing Liu	Human Resources Manager